phenylpiperazine has been researched along with Hemolysis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lv, PC; Sun, J; Wang, XY; Zhu, HL | 1 |
1 other study(ies) available for phenylpiperazine and Hemolysis
Article | Year |
---|---|
Discovery of a series of novel phenylpiperazine derivatives as EGFR TK inhibitors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; ErbB Receptors; Hemolysis; Humans; Mice; Models, Molecular; Molecular Conformation; Piperazines; Protein Kinase Inhibitors; Quantitative Structure-Activity Relationship; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |